South Dakota Investment Council Astrazeneca PLC Transaction History

South Dakota Investment Council

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$59.26 - $71.14 $5.46 Million - $6.55 Million	-92,086 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$55.72 - $67.12 $1.28 Million - $1.54 Million	-22,884 Reduced 19.9%	92,086 $6.11 Million
Q4 2021 Feb 08, 2022	SELL	$54.02 - $63.83 $1.27 Million - $1.5 Million	-23,500 Reduced 16.97%	114,970 $6.7 Million
Q3 2021 Nov 09, 2021	BUY	$55.56 - $60.79 $171,958 - $188,145	3,095 Added 2.29%	138,470 $8.32 Million
Q2 2021 Aug 11, 2021	SELL	$48.42 - $60.18 $1.2 Million - $1.49 Million	-24,830 Reduced 15.5%	135,375 $8.11 Million
Q1 2021 May 13, 2021	BUY	$47.16 - $54.44 $7.56 Million - $8.72 Million	160,205 New	160,205 $7.97 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of South Dakota Investment Council, based on Form 13F filings with the SEC.

Stay updated on South Dakota Investment Council with notifications on news.